Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2021; 09(10): E1530-E1535
DOI: 10.1055/a-1526-0754
Original article

Over-the-scope clip as first-line therapy for ulcers with high-risk bleeding stigmata is efficient compared to standard endoscopic therapy

Avanija Buddam
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
,
Sirish Rao
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
,
Jahnavi Koppala
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
,
Rajani Rangray
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
,
Abdullah Abdussalam
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
,
Sandeep Mukherjee
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
,
Subhash Chandra
Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, Nebraska, United States
› Author Affiliations
Preview

Abstract

Background and study aims Ulcers with high-risk stigmata have significant rebleeding rates despite standard endoscopic therapy. Data on over-the-scope clip (OTSC) for recurrent bleeding is promising but data on first line therapy is lacking. We report comparative outcomes of OTSC as first-line therapy versus standard endoscopic therapy in ulcers with high-risk stigmata.

Patients and methods Consecutive adults who underwent endoscopic therapy for ulcers with high-risk stigmata between July 2019 to September 2020 were included. Patients were grouped into OTSC or standard therapy based on first-line therapy used on index endoscopy. Outcomes measured included: 1) intra-procedural hemostasis based on endoscopic documentation of adequate hemostasis; 2) 7-day rebleeding (> 2 g/dL drop in hemoglobin, hematochezia or hemorrhagic shock); 3) cost of endoscopic interventions; and 4) procedure duration measured as endoscope insertion to removal time. Cost of tools used during the index endoscopy was included.

Results Sixty-eight patients were included, 47 were in standard therapy and 21 in the OTSC group. Hemostasis was achieved in 95.2 % in the OTSC group compared to 83.0 % in the standard therapy group (P = 0.256, number needed to treat [NNT]: 9). Procedure time was shorter in the OTSC group (23 vs. 16 minutes, P = 0.002). Cost of endoscopic interventions were comparable, P = 0.203. Early rebleeding was less often in OTSC group, two (9.5 %) compared to 10 (21.3 %) in standard therapy group, NNT 9.

Conclusions Use of OTSCs as first-line treatment for ulcers bleed probably improves hemostasis and decreases early rebleeding. Use of OTSC as first-line therapy shortened procedure duration without increasing the cost of endoscopic interventions.



Publication History

Received: 22 February 2021

Accepted: 04 June 2021

Article published online:
16 September 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany